spacer

International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
 
European Pharmaceutical Contractor
European Pharmaceutical Contractor
The EPC edition is designed to fill a unique position in pharmaceutical contractor publishing.
 
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
 
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
 
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
 
Clinical Trial Supply
The Drivers of Success in Ancillary Supply Chain Management

Dr Joanne Santomauro at Ancillare

While pharma companies increasingly focus on outsourcing efforts, effective ancillary supply chain management is often neglected.

 
The Elephant in the Room

Kurt Mussina at Frenova Renal Research

Systematic and concrete marketing activities are an often overlooked aspect of a successful clinical research business.

 

 
Features
Eschewing the Escalation of Salaries as Safety Professionals Grow Scarcer

Alan White at Arriello

Qualified PV professionals are proving particularly hard to hang on to as demand for experienced safety talent soars. As such, it seems like a good time to look beyond financial remuneration as the key to keeping valued staff motivated and loyal.
 
Green Supply Chain
Sustainable Supply Chains

Greg Wheatley at Peli BioThermal

The packaging industry is steadily improving the balance between effective pharmaceutical protection and minimal environmental impact.

 

 

Website design and development by Rubler Studio
spacer

Member login

E-mail address:

Password:
Remember me

.
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

.
White Papers

Accelerating the Time from DNA to Material

Merck

Cell line development is a critical step in upstream process development for monoclonal antibodies (mAbs). Unfortunately, the search for the bestproducing clone can be labor- and resource-intensive and is often compared with looking for a needle in a haystack. Cells must first be engineered to produce the biologic of interest and the cell line generated from a high producing clone must deliver a sufficiently high titer to support clinical studies, and ultimately commercialization of the therapeutic.
More info >>



Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement